Cisplatin-induced skeletal muscle atrophy is believed to be associated with not only the activation of muscle-specific ubiquitin ligases, but also reduced levels of IGF1, MyoD1, and myogenin [11,40,41,42,43,44]. Here, MYOD1 is linked to muscular atrophy.